Dekkers Leaves Thermo Fisher for Bayer | GenomeWeb

NEW YORK (GenomeWeb News) – Marijn Dekkers has resigned his position as president, CEO, and member of the board of directors at Thermo Fisher Scientific to take over as CEO of German drug, chemicals, and life science giant Bayer.

Thermo Fisher has appointed current COO Marc Casper to become president, CEO, and board member effective Oct. 15, 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.